Associations Between Mutations of DNA Damage Response and Prognosis in Microsatellite Instability Prevalent Tumors.
Zhijie Wang,Jing Zhao,Guoqiang Wang,Yuzi Zhang,Hao Qin,Shangli Cai,Jianchun Duan,Hua Bai,Jie Wang
DOI: https://doi.org/10.1200/jco.2018.36.15_suppl.e24257
IF: 45.3
2018-01-01
Journal of Clinical Oncology
Abstract:e24257 Background: DNA damage response (DDR) system is necessary for genomic stability, whose mutations may be associated with improved sensitivity to DNA breaks agents, including platinum. Uterine Corpus Endometrial Carcinoma (UCEC), Colorectal Adenocarcinoma (COAD-READ) and Stomach Adenocarcinoma (STAD) are characterized as high prevalence of microsatellite instability (MSI) which indicates genomic instability, whose standard adjuvant treatment contains platinum. We hypothesize that DDR genes alterations are associated with MSI and prognosis in resected UCEC, STAD and COAD-READ. Methods: Whole-exome sequencing (WES) data of 530 UCEC, 437 STAD and 536 COAD-READ from The Cancer Genome Atlas were analyzed to explore the associations between 29 DDR mutations and MSI or prognosis. Results: The frequency of at least one deleterious DDR mutation was 45.9%, 26.5%, 37.9% in UCEC, STAD and COAD-READ, respectively. The mostly frequently mutated genes in UCEC, STAD and COAD-READ were ATM (17, 9, 14%), BRCA2 (15, 9, 8%), PRKDC (17, 10, 10%) and POLE (15, 6, 6%). DDR mutations were significantly associated with MSI-H (Mutation frequency in MSI-H/MSS: 85.2/28.3% in UCEC, 92.9/9.1% in STAD, 93.5/28.1% in COAD-READ, all P < 0.001). In UCEC, higher DDR mutations burden (at least 3 DDR mutations) was significantly associated with both disease free survival (DFS) and overall survival (OS) after adjusted for age (Hazard ratio (HR) = 0.28, 95% CI = 0.14-0.56 for DFS, HR = 0.24, 95% CI = 0.10-0.56 for OS). Besides, the HRs of DDR mutations with DFS or OS decreased with the increased counts of DDR mutations (P trend < 0.001 for DFS, < 0.001 for OS). In STAD, higher DDR mutations burden were significantly associated with both DFS and OS after adjusted for age, sex and pathological stage (HR = 0.51, 95% CI = 0.26-0.99 for DFS, HR = 0.58, 95% CI = 0.34-0.91 for OS). The HRs of DDR mutations with OS also decreased with the increased DDR mutations burden (P trend = 0.006). No associations were observed in COAD-READ. Conclusions: Deleterious DDR genes mutations were potential predictive biomarker for resected MSI prevalent tumors. Further studies are needed to validate their predictive roles in various adjuvant treatments.